Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06555575Phase 2Recruiting
Phase 2, randomised, open-label trial of coenzyme q10 in infertility (3 arms), sponsored by Trio Fertility. Primary endpoint: Fertilized oocyte percentage at 1 year. Started Jan 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06555575.